Suppr超能文献

[PPARγ基因Pro12Ala多态性对2型糖尿病患者内皮损伤的影响]

[Influence of polymorphism pro12Ala of PPARgamma gene on endothelium destruction in patients with diabetes mellitus t. 2].

作者信息

Gacka Małgorzata, Dobosz Tadeusz, Szymaniec Stanisław, Bednarska-Chabowska Dorota, Adamiec Rajmund

机构信息

Katedra i Klinika Angiologii, Nadciśnienia Tetniczego i Diabetologii AM we Wrocławiu.

出版信息

Pol Arch Med Wewn. 2005 Nov;114(5):1055-65.

Abstract

UNLABELLED

The peroxisome proliferator-activated receptor gamma (PPARgamma) influences wide on metabolism and atheromatosus processes in vessels. The common polymorphic form of PPARy, Pro12Ala, could promote diabetes mellitus and diabetic vascular complications.

AIM OF WORK

The assessment of indicators of endothelium destruction in patients with diabetes mellitus t.2 in relation to the polymorphism Pro12Ala of PPARgamma.

PATIENTS AND METHODS

Circulating blood endothelium cells (immunofluorescens method with MoAb CLB-HEC19), thrombomodulin (Asserchrom Immunoassay) and polymorphism Pro12Ala [minisequence technic SnaPshot (Applera); ABI+PRISM310] were investigated in 58 patients with diabetes mellitus typ 2 and 22 healthy persons. Fibrinogen, uric acid, lipids, HbA1c, glucose, insulin concentration, blood pressure, BMI and WHR were evaluated too.

RESULTS

The significant higher systolic (137.92 +/- 15.88 vs 122.0 +/- 15,67 [mmHg]; p < 0.025) and diastolic (85.00 +/- 7.38 vs 75.50 +/- 7.61 [mmHg]; p < 0.011) was determined in the group of healthy people, who have got a homozygous genotyp Pro12Pro in comparison with heterozygous genotyp Pro12Ala. The significant higher value of HbA1c was determined in the patients with diabetes mellitus t.2, who have got genotyp Pro12Ala in comparison with genotyp Pro12Pro (7.01 +/- 1.54 vs 8.39 +/- 1.81 [%]; p < 0.006). There was any significant difference for others parameters. Among people, which have got genotyp Pro12Pro there was significant difference between healthy and patients for circulating blood endothelium cells (2.19 +/- 1.53 vs 0.78 +/- 0.09 [EC/ml]; p < 0.009). On the contrary among people with genotype Pro12Ala there was not significant difference between healthy and patients for circulating blood endothelium cells (2.95 +/- 1.64 vs 1.61 +/- 1.08; p = 0.077 [EC/ml]).

CONCLUSIONS

  1. The polymorphism Pro12Ala is not connected with the endothelium destruction. 2) Other researches are necessary to estimate influence of mutated allele on the control of diabetes. 3) The genotyp Pro12Pro promotes higher blood pressure by healthy people.
摘要

未标注

过氧化物酶体增殖物激活受体γ(PPARγ)对血管中的代谢和动脉粥样硬化过程有广泛影响。PPARγ的常见多态性形式Pro12Ala可能会促进糖尿病及糖尿病血管并发症。

工作目的

评估2型糖尿病患者中与PPARγ基因Pro12Ala多态性相关的内皮细胞损伤指标。

患者与方法

对58例2型糖尿病患者和22例健康人进行了循环血内皮细胞(使用单克隆抗体CLB-HEC19的免疫荧光法)、血栓调节蛋白(Asserchrom免疫测定法)以及Pro12Ala多态性[小序列技术SnaPshot(应用生物系统公司);ABI+PRISM310]的检测。同时还评估了纤维蛋白原、尿酸、血脂、糖化血红蛋白、血糖、胰岛素浓度、血压、体重指数和腰臀比。

结果

与杂合基因型Pro12Ala相比,具有纯合基因型Pro12Pro的健康人群收缩压(137.92±15.88 vs 122.0±15.67[mmHg];p<0.025)和舒张压(85.00±7.38 vs 75.50±7.61[mmHg];p<0.011)显著更高。与基因型Pro12Pro相比,具有基因型Pro12Ala的2型糖尿病患者糖化血红蛋白值显著更高(7.01±1.54 vs 8.39±1.81[%];p<0.006)。其他参数无显著差异。在具有基因型Pro12Pro的人群中,健康人与患者的循环血内皮细胞存在显著差异(2.19±1.53 vs 0.78±0.09[EC/ml];p<0.009)。相反,在具有基因型Pro12Ala的人群中,健康人与患者的循环血内皮细胞无显著差异(2.95±1.64 vs 1.61±1.08;p = 0.077[EC/ml])。

结论

1)Pro12Ala多态性与内皮细胞损伤无关。2)需要进一步研究来评估突变等位基因对糖尿病控制的影响。3)基因型Pro12Pro使健康人血压更高。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验